Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00948532 · ClinicalTrials.gov registry record
Osteocel® Plus in eXtreme Lateral Interbody Fusion (XLIF®)
A clinical trial, sponsored by NuVasive.
- Completed
- Registry status
- 104
- Enrollment target
NCT00948532: Completed study, sponsored by NuVasive.
NCT00948532 is a clinical trial that has completed, run by NuVasive. The registered enrollment target is 104 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00948532 has completed, sponsored by NuVasive.
- COMPLETED
- Registry status
- 104 participants
- Enrollment target
Study Summary
This is a prospective, non-randomized multi-center study to compare the use of Osteocel® Plus in subjects who receive XLIF® (eXtreme Lateral Interbody Fusion) surgery at one or two levels. These subjects will present with degenerative conditions in the lumbar spine that are amenable to surgical treatment and will be screened prior to study enrollment. Subjects will receive Osteocel Plus during their XLIF operation. Subjects will be followed for 24-months following surgery to determine the number of study subjects that are solidly fused at or before 24 months postoperatively, and to determine the mean time to fusion. This data will be compared to published and/or retrospective data for autograft, synthetic ceramics and Bone Morphogenetic Protein (BMP).
Interventions
- BIOLOGICAL biologic, Osteocel Plus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 104 participants |
| Start Date | 2009-03 |
| Est. Completion | 2012-10 |
What the finished NCT00948532 record still lists
NCT00948532 is an observational study that tracks outcomes without assigning an intervention. The registered 104 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which biologic, Osteocel Plus is the first listed.
NCT00948532 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00948532 about?
NCT00948532 is a clinical study titled "Osteocel® Plus in eXtreme Lateral Interbody Fusion (XLIF®)". This is a prospective, non-randomized multi-center study to compare the use of Osteocel® Plus in subjects who receive XLIF® (eXtreme Lateral Interbody Fusion) surgery at one or two levels. These subjects will present with degenerative conditions in the lumbar spine that are amenable to surgical trea...
What is the current status of trial NCT00948532?
This trial is currently completed. The enrollment target is 104 participants. The study started on 2009-03. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00948532?
The interventions under investigation include: biologic, Osteocel Plus (BIOLOGICAL).
Who is sponsoring clinical trial NCT00948532?
This trial is sponsored by NuVasive, which has 28 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03403686 · 104 participants
Liver X Receptor (LXR) as a Novel Therapeutic Target in Diabetic Retinopathy (DR)
- NCT04228367 · 104 participants · NA
JuggerStitch Post Market Clinical Follow-up Study
- NCT04268849 · 104 participants · Phase 3
Trial of IV vs Oral Iron Treatment of Iron Deficiency Anemia in the Post-Operative Bariatric Surgical Patient
- NCT04390724 · 104 participants
Optimizing Y90 Therapy for Radiation Lobectomy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia